Csk Bio Consulting Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 59.90%
- Profit Growth 126.64%
- Ebitda 125.27%
- Net Worth 77.06%
- Total Assets 149.70%
About Csk Bio Consulting
Csk Bio Consulting Private Limited (CBCPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 December 2011 and has a history of 13 years and one month. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Dahiya and Niti Chaudhary serve as directors at the Company.
Company Details
-
Location
New Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U40300DL2011PTC229370
-
Company No.
229370
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Dec 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Csk Bio Consulting?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Dahiya
|
Additional Director | 30-Mar-2022 | Current |
|
Niti Chaudhary
|
Director | 28-Dec-2011 | Current |
Financial Performance of Csk Bio Consulting.
Csk Bio Consulting Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.9% increase. The company also saw a substantial improvement in profitability, with a 126.64% increase in profit. The company's net worth Soared by an impressive increase of 77.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Csk Bio Consulting?
In 2023, Csk Bio Consulting had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aegis Bio Consulting Private LimitedAmit Dahiya and Niti Chaudhary are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Csk Bio Consulting?
Csk Bio Consulting has a workforce of 15 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Csk Bio Consulting, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Csk Bio Consulting's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
